XFOR X4 Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases... Show more
XFOR is expected to report earnings to rise 14.56% to -18 cents per share on August 06
Q2'26
Est.
$-0.18
Q1'26
Missed
by $0.04
Q4'25
Missed
by $0.11
Q3'25
Missed
by $0.56
Q2'25
Missed
by $3.38
The last earnings report on May 06 showed earnings per share of -15 cents, missing the estimate of -11 cents. With 352.42K shares outstanding, the current market capitalization sits at 377.56M.
A.I. Advisor
published General Information
General Information
a biotechnology company which engages in developing human antibodies for treating infectious diseases
A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with TNXP. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then TNXP could also see price increases.
XFOR in upward trend: price may jump up because it broke its lower Bollinger Band on May 18, 2026
XFOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where XFOR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where XFOR's RSI Indicator exited the oversold zone, of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 16, 2026. You may want to consider a long position or call options on XFOR as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for XFOR just turned positive on June 15, 2026. Looking at past instances where XFOR's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
XFOR moved above its 50-day moving average on June 18, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XFOR advanced for three days, in of 231 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for XFOR crossed bearishly below the 50-day moving average on May 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XFOR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for XFOR entered a downward trend on May 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.307) is normal, around the industry mean (20.966). P/E Ratio (0.706) is within average values for comparable stocks, (36.007). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.690). XFOR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (33.003) is also within normal values, averaging (367.026).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XFOR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XFOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
